Hepatitis due to erythromycin propionate
Pessayre, D.; Marie, C.; Benhamou, J.P.
Archives Francaises des Maladies de l'Appareil Digestif 65(5): 405-408
1976
ISSN/ISBN: 0003-9772 PMID: 1008656 Document Number: 105304
Document emailed within 1 workday
Related Documents
Ponsot, P.; Théodore, C.; Larrey, D.; Breil, P.; Hugentobler, J.P.; Paolaggi, J.A. 1982: Acute hepatitis caused by erythromycin propionate Gastroenterologie Clinique et Biologique 6(6-7): 594Luherne, J.Y.; Pariente, E.A.; Maitre, F. 1988: Crossed hepatotoxicity of erythromycin propionate and troleandomycin? Gastroenterologie Clinique et Biologique 12(11): 869-870
Funck-Brentano, C.; Danan, G.; Pessayre, D.; Benhamou, J.P. 1982: Hepatitis due to erythromycin ethylsuccinate Gastroenterologie Clinique et Biologique 6(12): 1044-1045
Gafter, U.; Mandel, E.M.; Weiss, S.; Djaldetti, M. 1979: Erythromycin estolate-induced hepatitis. Ultrastructural study of liver New York State Journal of Medicine 79(1): 87-89
Iankelevich, D.E.; Iurchenko, M.Z. 1970: The effect of prolonged administration of testosterone propionate and 2-alpha-methyldihyrotestosterone propionate on several functions of the adrenal cortex in female guinea pigs Problemy Endokrinologii 16(6): 70-73
Majer, J.; Stanaszek, R.S.; Mueller, S.L.; Marti, G. 1978: N-Didemethyl-n-propionyl-6,9;9, 12-erythromycin A-spiroketal, a new metabolite of erythromycin ethyl succinate in man Drug Metabolism and Disposition: the Biological Fate of Chemicals 6(6): 673-676
Klita, S.; Szafranśki, P. 1980: Comparison of the mechanism of action of cyclic 11,12-erythromycin a carbonate and erythromycin a Acta Biochimica Polonica 27(3-4): 213-220
Breneman, D.; Fleischer, A.B.; Kaplan, D.; Lebwohl, M.; Miller, B.; Pariser, D.; Rist, T.; Swinyer, L.; Liu, Y.; Foley, V. 2005: Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream Journal of Drugs in Dermatology: Jdd 4(3): 330-336
Murphy, P.J.; Williams, T.L.; McMahon, R.E.; Marshall, F.J. 1975: Metabolism of propionyl erythromycin lauryl sulfate. I. Fate of the propionyl erythromycin moiety in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 3(3): 155-163
Kupryś-Lipińska, I.; Tworek, D.; Vanderbist, F.; Bocheńska-Marciniak, M.łg.; Kuna, P. 2013: Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma Pneumonologia i Alergologia Polska 81(6): 527-536
Sheffer, A.L.; LaForce, C.; Chervinsky, P.; Pearlman, D.; Schaberg, A. 1996: Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group Journal of Family Practice 42(4): 369-375
Hazato, H.; Yamamoto, T.; Tadokoro, I.; Kawamura, A.; Suzuki, K. 1973: Josamycin propionate. 4. Toxicity Japanese Journal of Antibiotics 26(2): 136-147
Johnson, M. 1996: Fluticasone propionate: safety profile Cutis 57(2 Suppl): 10-12
Islam, N.; Islam, A. 1973: Testosterone propionate in cirrhosis of the liver British Journal of Clinical Practice 27(4): 125-128
Dölle, W. 1979: Erythromycin Deutsche Medizinische Wochenschrift 104(38): 1330
Kjaeldgaard, P.; Friis, H.; Colding, H. 1984: Erythromycin Ugeskrift for Laeger 146(40): 3050-3051
Ari, A. 1977: Epidemiology of viral hepatitis: hepatitis A, hepatitis B and unclassified hepatitis Turk Hijiyen Ve Deneysel Biyoloji Dergisi. Turkish Bulletin of Hygiene and Experimental Biology 37(1): 71-86
El-Sayed, N.M.; el-Halawani, T.A. 1995: Comparative study of serum and salivary hepatitis B surface antigen and hepatitis C antibodies among patients infected with hepatitis B or C virus Egyptian Dental Journal 41(3): 1305-1312
Stevens, C.E.; Taylor, P.E.; Tong, M.J.; Toy, P.T.; Vyas, G.N.; Nair, P.V.; Weissman, J.Y.; Krugman, S. 1987: Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission JAMA 257(19): 2612-2616
Hradil, E.; Lindström, C.; Möller, H. 1978: Intermittent treatment of psoriasis with clobetasol propionate Acta Dermato-Venereologica 58(4): 375-377